Drug
TG 1701
TG 1701: highest development phase Phase 1, developed by TG Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- TG Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| TG-1701 NCT03671590 | Phase 1 | Non Hodgkin Lymphoma |
Latest
No recent events.
Follow TG 1701 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.